Edition:
United Kingdom

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

3,551JPY
22 Aug 2019
Change (% chg)

¥25 (+0.71%)
Prev Close
¥3,526
Open
¥3,531
Day's High
¥3,554
Day's Low
¥3,493
Volume
4,561,800
Avg. Vol
5,361,110
52-wk High
¥4,943
52-wk Low
¥3,493

About

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and... (more)

Overall

Beta: 0.80
Market Cap(Mil.): ¥5,755,279.00
Shares Outstanding(Mil.): 1,576.36
Dividend: 90.00
Yield (%): 4.93

Financials

  4502.T Industry Sector
P/E (TTM): 21.24 29.73 33.85
EPS (TTM): 171.88 -- --
ROI: 1.48 13.04 12.69
ROE: 3.05 14.12 17.13

Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development deals with partners, the company's chief executive told Reuters.

14 Aug 2019

Germany's Stada 'very selective' on acquisitions: CEO Goldschmidt

FRANKFURT German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development deals with partners, the company's chief executive told Reuters.

14 Aug 2019

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development deals with partners, the company's chief executive told Reuters.

14 Aug 2019

Japan stocks edge up, weaker yen offsets Fed disappointment

TOKYO, Aug 1 Japan's Nikkei share average recouped early losses and ended marginally higher on Thursday, supported by a weaker yen which helped offset disappointment that the U.S. Federal Reserve is not embarking on a lengthy easing cycle.

01 Aug 2019

Japan stocks inch up, weak yen helps offset Fed disappointment

TOKYO, Aug 1 Japan's Nikkei share average recouped early losses and inched up on Thursday, supported by a weaker yen which helped offset disappointment that the U.S. Federal Reserve is not embarking on a lengthy easing cycle.

01 Aug 2019

Deals of the day-Mergers and acquisitions

July 17 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:

17 Jul 2019

Takeda kicks off sale of Western European drugs - sources

FRANKFURT/LONDON Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in western Europe as it seeks to trim its debt following the $59 billion purchase of Shire, sources close to the matter told Reuters.

17 Jul 2019

Takeda kicks off sale of Western European drugs: sources

FRANKFURT/LONDON Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in western Europe as it seeks to trim its debt following the $59 billion purchase of Shire, sources close to the matter told Reuters.

17 Jul 2019

Takeda kicks off sale of Western European drugs - sources

FRANKFURT/LONDON, July 17 Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in western Europe as it seeks to trim its debt following the $59 billion purchase of Shire, sources close to the matter told Reuters.

17 Jul 2019

Dealmakers seek new opportunities in M&A slowdown as trade war lingers

HONG KONG Dealmakers in Asia are seeking to turn ongoing China-U.S. trade tensions to their advantage even as fears of ramped-up hostility between the two countries disrupt markets and damp cross-border mergers and acquisitions (M&As).

28 Jun 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates